General Gastro News Articles

Gastro

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Klos A et al. – C5aR exerts detrimental functions in acute colitis, strongly supporting the idea that a C5aR–antagonist might be useful for IBD treatment. However, since the absence of C5aR was no longer protective and in some regards disadvantageous in chronic IBD, future studies should address the efficacy and the possible side effects of a sustained antagonist treatment.

Related Articles

Novel Diagnostic and Prognostic Modalities in Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/17/09    Relevance Score: 83%

Pregnancy and Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/17/09    Relevance Score: 83%

Pathogenesis of inflammatory bowel disease (IBD)
The Internet Journal of Gastroenterology, 11/13/09    Relevance Score: 83%

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
The Lancet, 11/09/09    Relevance Score: 83%

Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history
Expert Review of Gastroenterology & Hepatology, 10/13/09    Relevance Score: 83%

Today in Inflammatory Bowel Dz...keeping you current

Clinical outcomes of ileorectal anastomosis for ulcerative colitis
British Journal of Surgery, 12/11/09

Capsule endoscopy in suspected small bowel Crohn's disease: Economic impact of disease diagnosis and treatment
World Journal of Gastroenterology, 12/11/09

Effect of exclusive enteral nutrition on bone turnover in children with Crohn's disease
Journal of Gastroenterology, 12/10/09

Today in Pharmacology/kinetics...keeping you current

Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update
Clinical and Experimental Gastroenterology, 12/11/09

Chemoprevention in Barrett's Esophagus: Are We There Yet, Are We There Yet...
Clinical Gastroenterology and Hepatology , 12/11/09

Inhibitory effect of emodin and Astragalus polysaccharide on the replication of HBV
World Journal of Gastroenterology, 12/11/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address